Zahabia Adnan: Meta-Analysis Supports Rivaroxaban as an Effective Option for Cancer-Associated VTE
Zahabia Adnan, Research Executive at Student Research Form-SMC, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Clinical and Applied Thrombosis/Hemostasis, adding:
“I’m pleased to share our recently published systematic review and meta-analysis, ‘Rivaroxaban versus Low Molecular Weight Heparin for Cancer-Associated Venous Thromboembolism,’ in Clinical and Applied Thrombosis/Hemostasis.
Analyzing data from 25 studies and 19,153 patients, our findings indicate that rivaroxaban was associated with a significant reduction in both VTE recurrence and all-cause mortality compared to low molecular weight heparin in patients with cancer-associated thrombosis.
These results contribute to the evolving evidence on anticoagulant selection in oncology and highlight the need for continued large-scale trials.
I’m grateful for the invaluable contributions of my co-authors for making this project successful.
Hoping to work on more projects too.
Do give a read to it.”
Title: Rivaroxaban versus Low Molecular Weight Heparin for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis
Authors: Zahabia Adnan, Syed Ibad Hussain, Amna Amir Jalal, Ayesha Shaukat, Eisha Abid, Muhammad Burhan, Arsalan Ahmed, Eshal Saghir, Shaikh Muhammad Daniyal, Shanza Shakir, Abedin Samadi, Ahmed Asad Raza
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs